Subcellular distribution of intravenously injected 125I-labelled insulin in rat liver.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 7011865)

Published in Int J Biochem on January 01, 1981

Authors

D K Papachristodoulou, M S Birbeck, G S Scott, J H Thomas

Articles by these authors

(truncated to the top 100)

A Saccharomyces cerevisiae genomic plasmid bank based on a centromere-containing shuttle vector. Gene (1987) 19.68

Diverse effects of beta-tubulin mutations on microtubule formation and function. J Cell Biol (1988) 6.88

Isolation of the beta-tubulin gene from yeast and demonstration of its essential function in vivo. Cell (1983) 6.22

Genetic analysis of chemosensory control of dauer formation in Caenorhabditis elegans. Genetics (1992) 4.04

Isolation and characterization of mutations in the beta-tubulin gene of Saccharomyces cerevisiae. Genetics (1985) 3.77

A gene required for the separation of chromosomes on the spindle apparatus in yeast. Cell (1986) 3.32

A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans. Genes Dev (1999) 3.21

Chemosensory neurons function in parallel to mediate a pheromone response in C. elegans. Neuron (1996) 3.19

Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1999) 3.19

A transmembrane guanylyl cyclase (DAF-11) and Hsp90 (DAF-21) regulate a common set of chemosensory behaviors in caenorhabditis elegans. Genetics (2000) 2.90

Peanut lectin binding properties of germinal centres of mouse lymphoid tissue. Nature (1980) 2.79

The RFX-type transcription factor DAF-19 regulates sensory neuron cilium formation in C. elegans. Mol Cell (2000) 2.58

Mutations affecting the chemosensory neurons of Caenorhabditis elegans. Genetics (1995) 2.54

Chemosensory cell function in the behavior and development of Caenorhabditis elegans. Cold Spring Harb Symp Quant Biol (1990) 2.28

Studies on the enzymic degradation of L-serine O-sulphate by a rat liver preparation. Biochem J (1967) 2.17

Streptococcal infection in young pigs. II. Epidemiology and experimental production of the disease. J Hyg (Lond) (1966) 2.12

Genetic analysis of the roles of daf-28 and age-1 in regulating Caenorhabditis elegans dauer formation. Genetics (1996) 2.01

The C. elegans homolog of the murine cystic kidney disease gene Tg737 functions in a ciliogenic pathway and is disrupted in osm-5 mutant worms. Development (2001) 2.01

Sequence of C. elegans lag-2 reveals a cell-signalling domain shared with Delta and Serrate of Drosophila. Nature (1994) 1.90

aex-3 encodes a novel regulator of presynaptic activity in C. elegans. Neuron (1997) 1.86

The transport by hepatocytes of immunoglobulin A from blood to bile visualized by autoradiography and electron microscopy. Immunology (1979) 1.86

Genetic and pharmacological analysis of neurotransmitters controlling egg laying in C. elegans. J Neurosci (1995) 1.85

A screen for nonconditional dauer-constitutive mutations in Caenorhabditis elegans. Genetics (1994) 1.76

Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J (2000) 1.75

Regulation of a periodic motor program in C. elegans. J Neurosci (1994) 1.74

Dauer formation induced by high temperatures in Caenorhabditis elegans. Genetics (2000) 1.73

egl-4 acts through a transforming growth factor-beta/SMAD pathway in Caenorhabditis elegans to regulate multiple neuronal circuits in response to sensory cues. Genetics (2000) 1.71

Epiploic appendagitis. Surg Gynecol Obstet (1974) 1.64

eat-11 encodes GPB-2, a Gbeta(5) ortholog that interacts with G(o)alpha and G(q)alpha to regulate C. elegans behavior. Curr Biol (2001) 1.62

Dynamos in asymptotic-giant-branch stars as the origin of magnetic fields shaping planetary nebulae. Nature (2001) 1.51

Diverse behavioural defects caused by mutations in Caenorhabditis elegans unc-43 CaM kinase II. Nature (1999) 1.50

Transformation, in vivo, of basophilic lymph cells into plasma cells. Nature (1967) 1.49

Multiple chemosensory defects in daf-11 and daf-21 mutants of Caenorhabditis elegans. Genetics (1994) 1.43

Post-thyroidectomy hypocalcemia. Incidence and risk factors. Am J Surg (1986) 1.41

Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol (1998) 1.40

Observation of an antimatter hypernucleus. Science (2010) 1.38

Neurosecretory control of aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A (1999) 1.37

Calcium/calmodulin-dependent protein kinase II regulates Caenorhabditis elegans locomotion in concert with a G(o)/G(q) signaling network. Genetics (2000) 1.36

Influence of preformed antibody on experimental Streptococcus sanguis endocarditis. Infect Immun (1979) 1.36

Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology (1998) 1.34

Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci U S A (1998) 1.34

Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection. Am J Surg (1996) 1.32

Genes that control a temperature-compensated ultradian clock in Caenorhabditis elegans. Proc Natl Acad Sci U S A (1995) 1.30

Targets of TGF-beta signaling in Caenorhabditis elegans dauer formation. Dev Biol (2000) 1.30

The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity. J Immunol (2000) 1.27

Improving resectability and survival in patients with primary duodenal carcinoma. Am J Surg (1993) 1.26

Fluoxetine-resistant mutants in C. elegans define a novel family of transmembrane proteins. Mol Cell (1999) 1.25

Characteristics of cystic neoplasms of the pancreas and results of aggressive surgical treatment. Am J Surg (1992) 1.21

Pancreaticoduodenectomy for malignant pancreatic and periampullary neoplasms in elderly patients. Am J Surg (1991) 1.20

Interaction of rheumatoid factor with infectious herpes simplex virus-antibody complexes. Science (1971) 1.20

A radioautographic study of the hepatic uptake of circulating carcinoembryonic antigen by the mouse. Biochem Soc Trans (1977) 1.20

Pancreatogastrostomy: a safe drainage procedure after pancreatoduodenectomy. Surgery (1990) 1.18

The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J Immunol (2001) 1.14

The pyridoxal- and pyridoxal 5'-phosphate-catalysed non-enzymic degradations of l-serine o-sulphate and related compounds. Biochem J (1968) 1.13

Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12

Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11

The PAX gene egl-38 mediates developmental patterning in Caenorhabditis elegans. Development (1997) 1.10

The bromodomain protein LIN-49 and trithorax-related protein LIN-59 affect development and gene expression in Caenorhabditis elegans. Development (2000) 1.09

Identification and characterization of genes that interact with lin-12 in Caenorhabditis elegans. Genetics (1997) 1.09

Block of an ether-a-go-go-like K(+) channel by imipramine rescues egl-2 excitation defects in Caenorhabditis elegans. J Neurosci (1999) 1.07

Analysis of dominant mutations affecting muscle excitation in Caenorhabditis elegans. Genetics (1995) 1.07

Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76  TeV. Phys Rev Lett (2011) 1.05

Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1988) 1.04

Extrahepatic biliary obstruction secondary to metastatic cancer. Am J Surg (1981) 1.03

Tricuspid stenosis secondary to metastatic melanoma. Cancer (1977) 1.02

Mutants of a temperature-sensitive two-P domain potassium channel. J Neurosci (2000) 1.01

The use of detergents and immunoperoxidase reagents for the ultrastructural demonstration of internal immunoglobulin in lymph cells. J Immunol Methods (1978) 1.01

Transhiatal versus transthoracic esophagectomy for adenocarcinoma of the distal esophagus and cardia. Am J Surg (1996) 1.00

Characterization of seven genes affecting Caenorhabditis elegans hindgut development. Genetics (1999) 0.99

Genetics in rhythm. Trends Genet (1997) 0.99

The critical hypogastric circulation. Am J Surg (1987) 0.97

Hickman-Broviac catheters. Indications and results. Am J Surg (1980) 0.97

Significance of tumor spread in adenocarcinoma of the ampulla of Vater. Am J Surg (1989) 0.97

Strange baryon resonance production in sqrt s NN=200 GeV p+p and Au+Au collisions. Phys Rev Lett (2006) 0.96

Behavioral defects in C. elegans egl-36 mutants result from potassium channels shifted in voltage-dependence of activation. Neuron (1997) 0.95

Suppressors of transforming growth factor-beta pathway mutants in the Caenorhabditis elegans dauer formation pathway. Genetics (2000) 0.94

Transverse-momentum and collision-energy dependence of high-pT hadron suppression in Au+Au collisions at ultrarelativistic energies. Phys Rev Lett (2003) 0.93

Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2011) 0.93

Migration of asbestos fibres from subcutaneous injection sites in mice. Br J Cancer (1970) 0.93

Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid. Neurosci Lett (2000) 0.92

Electrophoresis of ( 35 S) sulphated insulin. Immunological and biological properties of the isolated electrophoretic components. Horm Metab Res (1971) 0.92

Evidence from d+Au measurements for final-state suppression of high-p(T) hadrons in Au+Au collisions at RHIC. Phys Rev Lett (2003) 0.92

SF6 plasma etching of silicon nanocrystals. Nanotechnology (2008) 0.92

Advanced gastric leiomyosarcoma. Am Surg (1989) 0.91

Thrombolytic therapy for catheter-related thrombosis. Am J Surg (1993) 0.89

Cell interactions involved in development of the bilaterally symmetrical intestinal valve cells during embryogenesis in Caenorhabditis elegans. Development (1992) 0.89

The use and abuse of digitalis in the elderly. Gerontol Clin (Basel) (1971) 0.88

Observations on the ultrastructure of two hamster lymphomas with particular reference to infiltrating macrophages. Int J Cancer (1972) 0.88

Studies on FeSV induced sarcomata in sheep with particular reference to the regional lymphatic system. Br J Cancer (1975) 0.88

Aortoiliac reconstruction combined with nonvascular operations. Am J Surg (1983) 0.87

Role of herniography in the diagnosis of occult hernias. Am J Surg (1991) 0.87

Requirement of intracellular calcium mobilization for peroxynitrite-induced poly(ADP-ribose) synthetase activation and cytotoxicity. Mol Pharmacol (1999) 0.86

The role of pancreatojejunostomy in patients without dilated pancreatic ducts. Am J Surg (1994) 0.85

Lysosomal changes and enhanced metastatic growth: an experimental study of the effects of some non-ionic surfactants. Int J Cancer (1971) 0.85

Immunochemical studies of high mobility group non-histone chromatin proteins HMG 1 and HMG 2. Exp Cell Res (1978) 0.85

Cost and effectiveness of a Geriatric Day Hospital. J R Coll Physicians Lond (1982) 0.84

Radioiodine therapy for differentiated thyroid carcinoma. Am J Surg (1988) 0.84

Aortoesophageal fistula: report of a successfully managed case and review of the literature. J Vasc Surg (1992) 0.84

Suppression of hadrons with large transverse momentum in central Au+Au collisions at root square[s(NN)] = 130 GeV. Phys Rev Lett (2001) 0.84

A novel cosmetic approach to treat thinning hair. Br J Dermatol (2011) 0.84